# Kiora Pharmaceuticals Inc: Form 8-K/A, filed Mar 5, 2021

- Company: [Kiora Pharmaceuticals Inc](/companies/kprx.md) (CIK 1372514)
- Form: 8-K/A
- Filed: 2021-03-05
- Accepted by EDGAR: Mar 5, 2021, 16:15 ET
- Period: 2020-12-18
- Accession: 0001104659-21-032744
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1372514/000110465921032744/tm218537d1_8ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1372514/000110465921032744/

## Items reported

- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1372514/000110465921032744/tm218537d1_8ka.htm

Filed Mar 5, 2021.
Source: SEC EDGAR, the filing index for accession 0001104659-21-032744. Last ingested by Listed: Nov 12, 2026, 17:43 ET. No prices; not investment advice.
